PART I . Overview We are a clinical stage global biopharmaceutical company developing novel oral small molecule therapeutics to treat a wide range of chronic diseases with unmet medical need. Our differentiated technology platform leverages both structure-based drug discovery and our expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). These important receptors regulate numerous and diverse physiological and patholo...
Q2 FY2026 — expected 2026-08-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001104659-26-020562 | EDGAR | 127K words |
| 2025-02-27 | 2024-12-31 | 0001558370-25-001826 | EDGAR | — |
| 2024-03-08 | 2023-12-31 | 0001558370-24-002791 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001558370-23-005141 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001104659-25-107829 | EDGAR | 81K words |
| 2025-08-06 | 2025-06-30 | 0001558370-25-010541 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001558370-25-006989 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001558370-24-015531 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011616 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007642 | EDGAR | — |
| 2023-11-17 | 2023-09-30 | 0001558370-23-019203 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014524 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009425 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-16 | 0001104659-26-028023 | EDGAR | 2K words |
| 2026-02-26 | 0001104659-26-020494 | EDGAR | — |
| 2026-01-05 | 0001104659-26-000620 | EDGAR | — |
| 2025-12-10 | 0001104659-25-120015 | EDGAR | — |
| 2025-12-08 | 0001104659-25-119095 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107740 | EDGAR | — |
| 2025-08-06 | 0001104659-25-074712 | EDGAR | — |
| 2025-06-25 | 0001104659-25-062576 | EDGAR | — |
| 2025-05-08 | 0001104659-25-046149 | EDGAR | — |
| 2025-02-27 | 0001104659-25-018275 | EDGAR | — |
54 total filings indexed. 31 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001888886 |
| Ticker | GPCR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | E9 |
| Website | https://www.structuretx.com |
| Listed | 2023-02-03 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report